[CLDX] YoY Annual Result on 31-Dec-2019 [#FY]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
26-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#FY]
Profit Trend
YoY- 66.68%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Annual Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 2,357 4,651 7,418 3,573 9,538 12,743 6,786 -16.15%
PBT -112,325 -70,738 -60,947 -50,878 -151,949 -117,313 -128,530 -2.22%
Tax 10,458 -227 -1,167 -506 -765 -24,282 -8,772 -
NP -122,783 -70,511 -59,780 -50,372 -151,184 -93,031 -128,530 -0.75%
Tax Rate - - - - - - - -
Total Cost 125,140 75,162 67,198 53,945 160,722 105,774 135,316 -1.29%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -5,209.29 -1,516.04 -805.88 -1,409.80 -1,585.07 -730.06 -1,894.05 18.35%
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -2.62 -1.64 -2.02 -3.47 -14.48 -10.86 -18.99 -28.10%
EPS Diluted -2.62 -1.64 -2.02 -3.47 -14.48 -10.86 -18.99 -28.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.